SCHEMBL13319702

SCHEMBL13319702

c1ccc(-c2c3ccc(-n4c5ccccc5c5ccccc54)cc3c(-c3ccccn3)c3ccc(-n4c5ccccc5c5ccccc54)cc23)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
ATM Q13315 1/20 0.43
CCR1 P32246 3/20 0.39
CCR5 P51681 3/20 0.39
CCR8 P51685 3/20 0.39
LMNA P02545 3/20 0.39
METAP1 P53582 2/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
BLM P54132 1/20 0.39
HIF1A Q16665 1/20 0.39
DOHH Q9BU89 1/20 0.39
P4HTM Q9NXG6 1/20 0.39
MAPK14 Q16539 1/20 0.39
DHFR P00374 2/20 0.39
MCL1 Q07820 5/20 0.37
ADORA3 P0DMS8 1/20 0.35
TP53 P04637 3/20 0.35
TDP1 Q9NUW8 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13319706 0.90 DHODH (0.39) KDM4EL3MBTL1ATMCCR1CCR5
SCHEMBL13319893 0.90 KDM4E (0.38) KDM4EL3MBTL1ATMCCR1CCR5
SCHEMBL13428008 0.87 MAPT (0.41) KDM4EL3MBTL1ATMLMNACYP1A2
SCHEMBL12613452 0.84 KDM4E (0.47) KDM4EL3MBTL1ATMCCR1CCR5
SCHEMBL13319874 0.84 FLT3 (0.41) LMNAMETAP1CYP1A2DHFRSMN1; SMN2
SCHEMBL13319763 0.82 METAP2 (0.41) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL13319728 0.82 DHFR (0.39) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL19654679 0.82 KDM4E (0.44) KDM4EL3MBTL1ATMCCR1CCR5
SCHEMBL13319816 0.81 CBFB (0.41) L3MBTL1ATMLMNADHFRSMN1; SMN2
SCHEMBL13351746 0.81 GRM5 (0.43) KDM4EATMMETAP1DHFRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299703-B2 Blue light emitting compound and organic light emitting diode device comprising the same LG DISPLAY CO., LTD. (KR) 2012-10-30 US disclosed
US-8299703-B2 Blue light emitting compound and organic light emitting diode device comprising the same LG DISPLAY CO., LTD. (KR) 2012-10-30 US disclosed
US-20100140603-A1 BLUE LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE COMPRISING THE SAME LG. DISPLAY CO. LTD. (KR) 2010-06-10 US disclosed
US-20100140603-A1 BLUE LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE COMPRISING THE SAME LG. DISPLAY CO. LTD. (KR) 2010-06-10 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A KDM4E 4138/4885L3MBTL1 1117/4885ATM 4252/4885
US-20100140603-A1 BLUE LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE COMPRISING THE SAME CRY1, CRY2, CYBA KDM4E 3622/4885L3MBTL1 146/4885ATM 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.